InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by POYHONEN JOHN, Président et Directeur Commercial. Director active across 2 companies, notably Heron Therapeutics, INC.. Cumulatively, 13 filings have been published. Activity tracked since 30 April 2021. The latest transaction was disclosed on 29 October 2021 (J). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
1,250 sharesCommon StockSEC:0001209191-23-024499:0
1,250 sharesCommon StockSEC:0001209191-23-003562:0
1,250 sharesCommon StockSEC:0001209191-22-053834:0
1,250 sharesCommon StockSEC:0001209191-22-042261:0
1,250 sharesCommon StockSEC:0001209191-22-024521:0
1,250 sharesCommon StockSEC:0001209191-22-003361
1,250 sharesCommon StockSEC:0001209191-22-003361:0
817 shares@ US$9.358518.5% of flowCommon StockSEC:0001209191-21-071173
817 shares@ US$9.35850.0027% mcap18.5% of flowCommon StockSEC:0001209191-21-071173:0
1,250 sharesCommon StockSEC:0001209191-21-060550:0
1,250 sharesCommon StockSEC:0001209191-21-060550
971 shares@ US$13.897531.5% of flowCommon StockSEC:0001209191-21-046789
971 shares@ US$13.89750.0045% mcap31.5% of flowCommon StockSEC:0001209191-21-046789:0
13 of 13 declarations
About POYHONEN JOHN
John Poyhonen is the President and Chief Commercial Officer of Heron Therapeutics, Inc. He leads the company's commercial and strategic initiatives. His experience in the pharmaceutical sector is essential for the development and marketing of Heron's products.
